Title: HEAL Act of 2018
Policy area: Health

Summary:
Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 or the HEAL Act of 2018
This bill establishes a series of requirements under Medicare and Medicaid relating to substance-use disorder prevention and treatment, including educational programs, screening requirements, and prescription drug monitoring.

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[S. 3120 Placed on Calendar Senate (PCS)]

<DOC>





                                                       Calendar No. 484
115th CONGRESS
  2d Session
                                S. 3120

                          [Report No. 115-284]

 To amend titles XVIII and XIX of the Social Security Act to help end 
    addictions and lessen substance abuse disorders, and for other 
                               purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             June 25, 2018

   Mr. Hatch, from the Committee on Finance, reported the following 
     original bill; which was read twice and placed on the calendar

_______________________________________________________________________

                                 A BILL


 
 To amend titles XVIII and XIX of the Social Security Act to help end 
    addictions and lessen substance abuse disorders, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

    (a) Short Title.--This Act may be cited as the ``Helping to End 
Addiction and Lessen Substance Use Disorders Act of 2018'' or the 
``HEAL Act of 2018''.
    (b) Table of Contents.--The table of contents for this Act is as 
follows:

Sec. 1. Short title; table of contents.
                           TITLE I--MEDICARE

Sec. 101. Medicare opioid safety education.
Sec. 102. Expanding the use of telehealth services for the treatment of 
                            opioid use disorder and other substance use 
                            disorders.
Sec. 103. Comprehensive screenings for seniors.
Sec. 104. Every prescription conveyed securely.
Sec. 105. Standardizing electronic prior authorization for safe 
                            prescribing.
Sec. 106. Strengthening partnerships to prevent opioid abuse.
Sec. 107. Commit to opioid medical prescriber accountability and safety 
                            for seniors.
Sec. 108. Fighting the opioid epidemic with sunshine.
Sec. 109. Demonstration testing coverage of certain services furnished 
                            by opioid treatment programs.
Sec. 110. Encouraging appropriate prescribing under Medicare for 
                            victims of opioid overdose.
Sec. 111. Automatic escalation to external review under a Medicare part 
                            D drug management program for at-risk 
                            beneficiaries.
Sec. 112. Medicare Improvement Fund.
                           TITLE II--MEDICAID

Sec. 201. Caring recovery for infants and babies.
Sec. 202. Peer support enhancement and evaluation review.
Sec. 203. Medicaid substance use disorder treatment via telehealth.
Sec. 204. Enhancing patient access to non-opioid treatment options.
Sec. 205. Assessing barriers to opioid use disorder treatment.
Sec. 206. Help for moms and babies.
Sec. 207. Securing flexibility to treat substance use disorders.
Sec. 208. MACPAC study and report on MAT utilization controls under 
                            State Medicaid programs.
Sec. 209. Opioid addiction treatment programs enhancement.
Sec. 210. Better data sharing to combat the opioid crisis.
Sec. 211. Mandatory reporting with respect to adult behavioral health 
                            measures.
Sec. 212. Report on innovative State initiatives and strategies to 
                            provide housing-related services and 
                            supports to individuals struggling with 
                            substance use disorders under Medicaid.
Sec. 213. Technical assistance and support for innovative State 
                            strategies to provide housing-related 
                            supports under Medicaid.
                       TITLE III--HUMAN SERVICES

Sec. 301. Supporting family-focused residential treatment.
Sec. 302. Improving recovery and reunifying families.
Sec. 303. Building capacity for family-focused residential treatment.

                           TITLE I--MEDICARE

SEC. 101. MEDICARE OPIOID SAFETY EDUCATION.

    (a) In General.--Section 1804 of the Social Security Act (42 U.S.C. 
1395b-2) is amended by adding at the end the following new subsection:
    ``(d) The notice provided under subsection (a) shall include--
            ``(1) references to educational resources regarding opioid 
        use and pain management;
            ``(2) a description of categories of alternative, non-
        opioid pain management treatments covered under this title; and
            ``(3) a suggestion for the beneficiary to talk to a 
        physician regarding opioid use and pain management.''.
    (b) Effective Date.--The amendment made by subsection (a) shall 
apply to notices distributed prior to each Medicare open enrollment 
period beginning after January 1, 2019.

SEC. 102. EXPANDING THE USE OF TELEHEALTH SERVICES FOR THE TREATMENT OF 
              OPIOID USE DISORDER AND OTHER SUBSTANCE USE DISORDERS.

    Section 1834(m) of the Social Security Act (42 U.S.C. 1395m(m)) is 
amended--
            (1) in paragraph (2)(B)--
                    (A) in clause (i), in the matter preceding 
                subclause (I), by striking ``clause (ii)'' and 
                inserting ``clause (ii) and paragraph (6)(C)''; and
                    (B) in clause (ii), in the heading, by striking 
                ``for home dialysis therapy'';
            (2) in paragraph (4)(C)--
                    (A) in clause (i), by striking ``paragraph (6)'' 
                and inserting ``paragraphs (5), (6), and (7)''; and
                    (B) in clause (ii)(X), by inserting ``or telehealth 
                services described in paragraph (7)(A)'' before the 
                period at the end; and
            (3) by adding at the end the following new paragraph:
            ``(7) Treatment of substance use disorder services 
        furnished through telehealth.--
                    ``(A) Non-application of originating site 
                geographic requirements.--The geographic requirements 
                described in paragraph (4)(C)(i) shall not apply with 
                respect to telehealth services furnished on or after 
                January 1, 2019, to an eligible telehealth individual 
                with a substance use disorder diagnosis for purposes of 
                treatment of such disorder, as determined by the 
                Secretary, at an originating site described in 
                paragraph (4)(C)(ii) (other than an originating site 
                described in subclause (IX) of such paragraph).
                    ``(B) Implementation.--The Secretary may implement 
                the provisions of this paragraph by interim final rule.
                    ``(C) Report.--Not later than 5 years after the 
                date of the enactment of this paragraph, the Secretary 
                shall submit to Congress a report on the impact of this 
                paragraph with respect to telehealth services on--
                            ``(i) the utilization of health care items 
                        and services related to substance use 
                        disorders, including emergency department 
                        visits; and
                            ``(ii) health outcomes related to substance 
                        use disorders, such as opioid overdose 
                        deaths.''.

SEC. 103. COMPREHENSIVE SCREENINGS FOR SENIORS.

    (a) Initial Preventive Physical Examination.--Section 1861(ww) of 
the Social Security Act (42 U.S.C. 1395x(ww)) is amended--
            (1) in paragraph (1)--
                    (A) by striking ``paragraph (2) and'' and inserting 
                ``paragraph (2),''; and
                    (B) by inserting ``and the furnishing of a review 
                of any current opioid prescriptions (as defined in 
                paragraph (4)),'' after ``upon the agreement with the 
                individual,''; and
            (2) in paragraph (2)--
                    (A) by redesignating subparagraph (N) as 
                subparagraph (O); and
                    (B) by inserting after subparagraph (M) the 
                following new subparagraph:
                    ``(N) Screening for potential substance use 
                disorders.''; and
            (3) by adding at the end the following new paragraph:
    ``(4) For purposes of paragraph (1), the term `a review of any 
current opioid prescriptions' means, with respect to an individual 
determined to have a current prescription for opioids--
            ``(A) a review of the potential risk factors to the 
        individual for opioid use disorder;
            ``(B) an evaluation of the individual's severity of pain 
        and current treatment plan;
            ``(C) the provision of information on non-opioid treatment 
        options; and
            ``(D) a referral to a pain management specialist, as 
        appropriate.''.
    (b) Annual Wellness Visit.--Section 1861(hhh)(2) of the Social 
Security Act (42 U.S.C. 1395x(hhh)(2)) is amended--
            (1) by redesignating subparagraph (G) as subparagraph (I); 
        and
            (2) by inserting after subparagraph (F) the following new 
        subparagraphs:
                    ``(G) Screening for potential substance use 
                disorders and referral for treatment as appropriate.
                    ``(H) The furnishing of a review of any current 
                opioid prescriptions (as defined in subsection 
                (ww)(4)).''.
    (c) Effective Date.--The amendments made by this section shall 
apply to examinations and visits furnished on or after January 1, 2019.

SEC. 104. EVERY PRESCRIPTION CONVEYED SECURELY.

    (a) In General.--Section 1860D-4(e) of the Social Security Act (42 
U.S.C. 1395w-104(e)) is amended by adding at the end the following:
            ``(7) Requirement of e-prescribing for controlled 
        substances.--
                    ``(A) In general.--Subject to subparagraph (B), a 
                prescription for a covered part D drug under a 
                prescription drug plan (or under an MA-PD plan) for a 
                schedule II, III, IV, or V controlled substance shall 
                be transmitted by a health care practitioner 
                electronically in accordance with an electronic 
                prescription drug program that meets the requirements 
                of paragraph (2).
                    ``(B) Exception for certain circumstances.--The 
                Secretary shall, through rulemaking, specify 
                circumstances and processes by which the Secretary may 
                waive the requirement under subparagraph (A), with 
                respect to a covered part D drug, including in the case 
                of--
                            ``(i) a prescription issued when the 
                        practitioner and dispensing pharmacy are the 
                        same entity;
                            ``(ii) a prescription issued that cannot be 
                        transmitted electronically under the most 
                        recently implemented version of the National 
                        Council for Prescription Drug Programs SCRIPT 
                        Standard;
                            ``(iii) a prescription issued by a 
                        practitioner who received a waiver or a renewal 
                        thereof for a period of time as determined by 
                        the Secretary, not to exceed one year, from the 
                        requirement to use electronic prescribing due 
                        to demonstrated economic hardship, 
                        technological limitations that are not 
                        reasonably within the control of the 
                        practitioner, or other exceptional circumstance 
                        demonstrated by the practitioner;
                            ``(iv) a prescription issued by a 
                        practitioner under circumstances in which, 
                        notwithstanding the practitioner's ability to 
                        submit a prescription electronically as 
                        required by this subsection, such practitioner 
                        reasonably determines that it would be 
                        impractical for the individual involved to 
                        obtain substances prescribed by electronic 
                        prescription in a timely manner, and such delay 
                        would adversely impact the individual's medical 
                        condition involved;
                            ``(v) a prescription issued by a 
                        practitioner prescribing a drug under a 
                        research protocol;
                            ``(vi) a prescription issued by a 
                        practitioner for a drug for which the Food and 
                        Drug Administration requires a prescription to 
                        contain elements that are not able to be 
                        included in electronic prescribing such as, a 
                        drug with risk evaluation and mitigation 
                        strategies that include elements to assure safe 
                        use;
                            ``(vii) a prescription issued by a 
                        practitioner--
                                    ``(I) for an individual who 
                                receives hospice care under this title; 
                                and
                                    ``(II) that is not covered under 
                                the hospice benefit under this title; 
                                and
                            ``(viii) a prescription issued by a 
                        practitioner for an individual who is--
                                    ``(I) a resident of a nursing 
                                facility (as defined in section 
                                1919(a)); and
                                    ``(II) dually eligible for benefits 
                                under this title and title XIX.
                    ``(C) Dispensing.--(i) Nothing in this paragraph 
                shall be construed as requiring a sponsor of a 
                prescription drug plan under this part, MA organization 
                offering an MA-PD plan under part C, or a pharmacist to 
                verify that a practitioner, with respect to a 
                prescription for a covered part D drug, has a waiver 
                (or is otherwise exempt) under subparagraph (B) from 
                the requirement under subparagraph (A).
                    ``(ii) Nothing in this paragraph shall be construed 
                as affecting the ability of the plan to cover or the 
                pharmacists' ability to continue to dispense covered 
                part D drugs from otherwise valid written, oral or fax 
                prescriptions that are consistent with laws and 
                regulations.
                    ``(iii) Nothing in this paragraph shall be 
                construed as affecting the ability of an individual who 
                is being prescribed a covered part D drug to designate 
                a particular pharmacy to dispense the covered part D 
                drug to the extent consistent with the requirements 
                under subsection (b)(1) and under this paragraph.
                    ``(D) Enforcement.--The Secretary shall, through 
                rulemaking, have authority to enforce and specify 
                appropriate penalties for non-compliance with the 
                requirement under subparagraph (A).''.
    (b) Effective Date.--The amendment made by subsection (a) shall 
apply to coverage of drugs prescribed on or after January 1, 2021.

SEC. 105. STANDARDIZING ELECTRONIC PRIOR AUTHORIZATION FOR SAFE 
              PRESCRIBING.

    Section 1860D-4(e)(2) of the Social Security Act (42 U.S.C. 1395w-
104(e)(2)) is amended by adding at the end the following new 
subparagraph:
                    ``(E) Electronic prior authorization.--
                            ``(i) In general.--Not later than January 
                        1, 2021, the program shall provide for the 
                        secure electronic transmittal of--
                                    ``(I) a prior authorization request 
                                from the prescribing health care 
                                professional for coverage of a covered 
                                part D drug for a part D eligible 
                                individual enrolled in a part D plan 
                                (as defined in section 1860D-23(a)(5)) 
                                to the PDP sponsor or Medicare 
                                Advantage organization offering such 
                                plan; and
                                    ``(II) a response, in accordance 
                                with this subparagraph, from such PDP 
                                sponsor or Medicare Advantage 
                                organization, respectively, to such 
                                professional.
                            ``(ii) Electronic transmission.--
                                    ``(I) Exclusions.--For purposes of 
                                this subparagraph, a facsimile, a 
                                proprietary payer portal that does not 
                                meet standards specified by the 
                                Secretary, or an electronic form shall 
                                not be treated as an electronic 
                                transmission described in clause (i).
                                    ``(II) Standards.--In order to be 
                                treated, for purposes of this 
                                subparagraph, as an electronic 
                                transmission described in clause (i), 
                                such transmission shall comply with 
                                technical standards adopted by the 
                                Secretary in consultation with the 
                                National Council for Prescription Drug 
                                Programs, other standard setting 
                                organizations determined appropriate by 
                                the Secretary, and stakeholders 
                                including PDP sponsors, Medicare 
                                Advantage organizations, health care 
                                professionals, and health information 
                                technology software vendors.
                                    ``(III) Application.--
                                Notwithstanding any other provision of 
                                law, for purposes of this subparagraph, 
                                the Secretary may require the use of 
                                such standards adopted under subclause 
                                (II) in lieu of any other applicable 
                                standards for an electronic 
                                transmission described in clause (i) 
                                for a covered part D drug for a part D 
                                eligible individual.''.

SEC. 106. STRENGTHENING PARTNERSHIPS TO PREVENT OPIOID ABUSE.

    (a) In General.--Section 1859 of the Social Security Act (42 U.S.C. 
1395w-28) is amended by adding at the end the following new subsection:
    ``(i) Program Integrity Transparency Measures.--
            ``(1) Program integrity portal.--
                    ``(A) In general.--Not later than 2 years after the 
                date of the enactment of this subsection, the Secretary 
                shall, after consultation with stakeholders, establish 
                a secure Internet website portal that would allow a 
                secure path for communication between the Secretary, MA 
                plans under this part, prescription drug plans under 
                part D, and an eligible entity with a contract under 
                section 1893 (such as a Medicare drug integrity 
                contractor or any successor entity to a Medicare drug 
                integrity contractor), in accordance with subsection 
                (j)(3) of such section, for the purpose of enabling 
                through such portal--
                            ``(i) the referral by such plans of 
                        suspicious activities of a provider of services 
                        (including a prescriber) or supplier related to 
                        fraud, waste, and abuse for initiating or 
                        assisting investigations conducted by the 
                        eligible entity; and
                            ``(ii) data sharing among such MA plans, 
                        prescription drug plans, and the Secretary.
                    ``(B) Required uses of portal.--The Secretary shall 
                disseminate the following information to MA plans under 
                this part and prescription drug plans under part D 
                through the secure Internet website portal established 
                under subparagraph (A):
                            ``(i) Providers of services and suppliers 
                        that have been referred pursuant to 
                        subparagraph (A)(i) during the previous 12-
                        month period.
                            ``(ii) Providers of services and suppliers 
                        who are the subject of an active exclusion 
                        under section 1128 or who are subject to a 
                        suspension of payment under this title pursuant 
                        to section 1862(o) or otherwise.
                            ``(iii) Providers of services and suppliers 
                        who are the subject of an active revocation of 
                        participation under this title, including for 
                        not satisfying conditions of participation.
                            ``(iv) In the case of such a plan that 
                        makes a referral under subparagraph (A)(i) 
                        through the portal with respect to suspicious 
                        activities of a provider of services (including 
                        a prescriber) or supplier, if such provider (or 
                        prescriber) or supplier has been the subject of 
                        an administrative action under this title or 
                        title XI with respect to similar activities, a 
                        notification to such plan of such action so 
                        taken.
                    ``(C) Rulemaking.--For purposes of this paragraph, 
                the Secretary shall, through rulemaking, specify what 
                constitutes suspicious activities related to fraud, 
                waste, and abuse, using guidance such as what is 
                provided in the Medicare Program Integrity Manual 
                4.7.1.
            ``(2) Quarterly reports.--Beginning not later than 2 years 
        after the date of the enactment of this subsection, the 
        Secretary shall make available to MA plans under this part and 
        prescription drug plans under part D in a timely manner (but no 
        less frequently than quarterly) and using information submitted 
        to an entity described in paragraph (1) through the portal 
        described in such paragraph or pursuant to section 1893, 
        information on fraud, waste, and abuse schemes and trends in 
        identifying suspicious activity. Information included in each 
        such report shall--
                    ``(A) include administrative actions, pertinent 
                information related to opioid overprescribing, and 
                other data determined appropriate by the Secretary in 
                consultation with stakeholders; and
                    ``(B) be anonymized information submitted by plans 
                without identifying the source of such information.
            ``(3) Clarification.--Nothing in this subsection shall 
        preclude or otherwise affect referrals to the Inspector General 
        of the Department of Health and Human Services or other law 
        enforcement entities.''.
    (b) Contract Requirement to Communicate Plan Corrective Actions 
Against Opioids Over-prescribers.--Section 1857(e)(4)(C) of the Social 
Security Act (42 U.S.C. 1395w-27(e)(4)(C)) is amended by adding at the 
end the following new paragraph:
            ``(5) Communicating plan corrective actions against opioids 
        over-prescribers.--
                    ``(A) In general.--Beginning with plan years 
                beginning on or after January 1, 2021, a contract under 
                this section with an MA organization shall require the 
                organization to submit to the Secretary, through the 
                process established under subparagraph (B), information 
                on credible evidence of suspicious activities of a 
                provider of services (including a prescriber) or 
                supplier related to fraud and other actions taken by 
                such plans related to inappropriate prescribing of 
                opioids.
                    ``(B) Process.--Not later than January 1, 2021, the 
                Secretary shall, in consultation with stakeholders, 
                establish a process under which MA plans and 
                prescription drug plans shall submit to the Secretary 
                information described in subparagraph (A).
                    ``(C) Regulations.--For purposes of this paragraph, 
                including as applied under section 1860D-12(b)(3)(D), 
                the Secretary shall, pursuant to rulemaking--
                            ``(i) specify a definition for the term 
                        `inappropriate prescribing of opioids' and a 
                        method for determining if a provider of 
                        services prescribes such a high volume; and
                            ``(ii) establish the process described in 
                        subparagraph (B) and the types of information 
                        that may be submitted through such process.''.
    (c) Reference Under Part D to Program Integrity Transparency 
Measures.--Section 1860D-4 of the Social Security Act (42 U.S.C. 1395w-
104) is amended by adding at the end the following new subsection:
    ``(m) Program Integrity Transparency Measures.--For program 
integrity transparency measures applied with respect to prescription 
drug plan and MA plans, see section 1859(i).''.

SEC. 107. COMMIT TO OPIOID MEDICAL PRESCRIBER ACCOUNTABILITY AND SAFETY 
              FOR SENIORS.

    Section 1860D-4(c)(4) of the Social Security Act (42 U.S.C. 1395w-
104(c)(4)) is amended by adding at the end the following new 
subparagraph:
                    ``(D) Notification and additional requirements with 
                respect to statistical outlier prescribers of 
                opioids.--
                            ``(i) Notification.--Not later than January 
                        1, 2021, the Secretary shall, in the case of a 
                        prescriber identified by the Secretary under 
                        clause (ii) to be a statistical outlier 
                        prescriber of opioids, provide, subject to 
                        clause (iv), an annual notification to such 
                        prescriber that such prescriber has been so 
                        identified that includes resources on proper 
                        prescribing methods and other information as 
                        specified in accordance with clause (iii).
                            ``(ii) Identification of statistical 
                        outlier prescribers of opioids.--
                                    ``(I) In general.--The Secretary 
                                shall, subject to subclause (III), 
                                using the valid prescriber National 
                                Provider Identifiers included pursuant 
                                to subparagraph (A) on claims for 
                                covered part D drugs for part D 
                                eligible individuals enrolled in 
                                prescription drug plans under this part 
                                or MA-PD plans under part C and based 
                                on the thresholds established under 
                                subclause (II), identify prescribers 
                                that are statistical outlier opioids 
                                prescribers for a period of time 
                                specified by the Secretary.
                                    ``(II) Establishment of 
                                thresholds.--For purposes of subclause 
                                (I) and subject to subclause (III), the 
                                Secretary shall, after consultation 
                                with stakeholders, establish 
                                thresholds, based on prescriber 
                                specialty and, as determined 
                                appropriate by the Secretary, 
                                geographic area, for identifying 
                                whether a prescriber in a specialty and 
                                geographic area is a statistical 
                                outlier prescriber of opioids as 
                                compared to other prescribers of 
                                opioids within such specialty and area.
                                    ``(III) Exclusions.--The following 
                                shall not be included in the analysis 
                                for identifying statistical outlier 
                                prescribers of opioids under this 
                                clause:
                                            ``(aa) Claims for covered 
                                        part D drugs for part D 
                                        eligible individuals who are 
                                        receiving hospice care under 
                                        this title.
                                            ``(bb) Claims for covered 
                                        part D drugs for part D 
                                        eligible individuals who are 
                                        receiving oncology services 
                                        under this title.
                                            ``(cc) Prescribers who are 
                                        the subject of an investigation 
                                        by the Centers for Medicare & 
                                        Medicaid Services or the 
                                        Inspector General of the 
                                        Department of Health and Human 
                                        Services.
                            ``(iii) Contents of notification.--The 
                        Secretary shall include the following 
                        information in the notifications provided under 
                        clause (i):
                                    ``(I) Information on how such 
                                prescriber compares to other 
                                prescribers within the same specialty 
                                and, if determined appropriate by the 
                                Secretary, geographic area.
                                    ``(II) Information on opioid 
                                prescribing guidelines, based on input 
                                from stakeholders, that may include the 
                                Centers for Disease Control and 
                                Prevention guidelines for prescribing 
                                opioids for chronic pain and guidelines 
                                developed by physician organizations.
                                    ``(III) Other information 
                                determined appropriate by the 
                                Secretary.
                            ``(iv) Modifications and expansions.--
                                    ``(I) Frequency.--Beginning 5 years 
                                after the date of the enactment of this 
                                subparagraph, the Secretary may change 
                                the frequency of the notifications 
                                described in clause (i) based on 
                                stakeholder input and changes in opioid 
                                prescribing utilization and trends.
                                    ``(II) Expansion to other 
                                prescriptions.--The Secretary may 
                                expand notifications under this 
                                subparagraph to include identifications 
                                and notifications with respect to 
                                concurrent prescriptions of covered 
                                Part D drugs used in combination with 
                                opioids that are considered to have 
                                adverse side effects when so used in 
                                such combination, as determined by the 
                                Secretary.
                            ``(v) Additional requirements for 
                        persistent statistical outlier prescribers.--In 
                        the case of a prescriber who the Secretary 
                        determines is persistently identified under 
                        clause (ii) as a statistical outlier prescriber 
                        of opioids, the following shall apply:
                                    ``(I) The Secretary shall provide 
                                an opportunity for such prescriber to 
                                receive technical assistance or 
                                educational resources on opioid 
                                prescribing guidelines (such as the 
                                guidelines described in clause 
                                (iii)(II)) from an entity that 
                                furnishes such assistance or resources, 
                                which may include a quality improvement 
                                organization under part B of title XI, 
                                as available and appropriate.
                                    ``(II) Such prescriber may be 
                                required to enroll in the program under 
                                this title under section 1866(j) if 
                                such prescriber is not otherwise 
                                required to enroll. The Secretary shall 
                                determine the length of the period for 
                                which such prescriber is required to 
                                maintain such enrollment.
                                    ``(III) Not less frequently than 
                                annually (and in a form and manner 
                                determined appropriate by the 
                                Secretary), the Secretary shall 
                                communicate information on such 
                                prescribers to sponsors of a 
                                prescription drug plan and Medicare 
                                Advantage organizations offering an MA-
                                PD plan.
                            ``(vi) Public availability of 
                        information.--The Secretary shall make 
                        aggregate information under this subparagraph 
                        available on the Internet website of the 
                        Centers for Medicare & Medicaid Services. Such 
                        information shall be in a form and manner 
                        determined appropriate by the Secretary and 
                        shall not identify any specific prescriber. In 
                        carrying out this clause, the Secretary shall 
                        consult with interested stakeholders.
                            ``(vii) Opioids defined.--For purposes of 
                        this subparagraph, the term `opioids' has such 
                        meaning as specified by the Secretary.
                            ``(viii) Other activities.--Nothing in this 
                        subparagraph shall preclude the Secretary from 
                        conducting activities that provide prescribers 
                        with information as to how they compare to 
                        other prescribers that are in addition to the 
                        activities under this subparagraph, including 
                        activities that were being conducted as of the 
                        date of the enactment of this subparagraph.''.

SEC. 108. FIGHTING THE OPIOID EPIDEMIC WITH SUNSHINE.

    (a) Inclusion of Information Regarding Payments to Advance Practice 
Nurses.--
            (1) In general.--Section 1128G(e)(6) of the Social Security 
        Act (42 U.S.C. 1320a-7h(e)(6)) is amended--
                    (A) in subparagraph (A), by adding at the end the 
                following new clauses:
                            ``(iii) A physician assistant, nurse 
                        practitioner, or clinical nurse specialist (as 
                        such terms are defined in section 1861(aa)(5)).
                            ``(iv) A certified registered nurse 
                        anesthetist (as defined in section 
                        1861(bb)(2)).
                            ``(v) A certified nurse-midwife (as defined 
                        in section 1861(gg)(2)).''; and
                    (B) in subparagraph (B), by inserting ``, physician 
                assistant, nurse practitioner, clinical nurse 
                specialist, certified nurse anesthetist, or certified 
                nurse-midwife'' after ``physician''.
            (2) Effective date.--The amendments made by this subsection 
        shall apply with respect to information required to be 
        submitted under section 1128G of the Social Security Act (42 
        U.S.C. 1320a-7h) on or after January 1, 2021.
    (b) Sunset of Exclusion of National Provider Identifier of Covered 
Recipient in Information Made Publicly Available.--Section 
1128G(c)(1)(C)(viii) of the Social Security Act (42 U.S.C. 1320a-
7h(c)(1)(C)(viii))) is amended by striking ``does not contain'' and 
inserting ``in the case of information made available under this 
subparagraph prior to January 1, 2021, does not contain''.
    (c) Administration.--Chapter 35 of title 44, United States Code, 
shall not apply to this section or the amendments made by this section.

SEC. 109. DEMONSTRATION TESTING COVERAGE OF CERTAIN SERVICES FURNISHED 
              BY OPIOID TREATMENT PROGRAMS.

    Title XVIII of the Social Security Act (42 U.S.C. 1395 et seq.) is 
amended by inserting after section 1866E the following:

   ``demonstration testing coverage of certain services furnished by 
                       opioid treatment programs

    ``Sec. 1866F.  (a) Establishment.--
            ``(1) In general.--The Secretary shall conduct a 
        demonstration (in this section referred to as the 
        `demonstration') to test coverage of and payment for opioid use 
        disorder treatment services (as defined in paragraph (2)(B)) 
        furnished by opioid treatment programs (as defined in paragraph 
        (2)(A)) to individuals under part B using a bundled payment as 
        described in paragraph (3).
            ``(2) Definitions.--In this section:
                    ``(A) Opioid treatment program.--The term `opioid 
                treatment program' means an entity that is an opioid 
                treatment program (as defined in section 8.2 of title 
                42 of the Code of Federal Regulations, or any successor 
                regulation) that--
                            ``(i) is selected for participation in the 
                        demonstration;
                            ``(ii) has in effect a certification by the 
                        Substance Abuse and Mental Health Services 
                        Administration for such a program;
                            ``(iii) is accredited by an accrediting 
                        body approved by the Substance Abuse and Mental 
                        Health Services Administration;
                            ``(iv) submits to the Secretary data and 
                        information needed to monitor the quality of 
                        services furnished and conduct the evaluation 
                        described in subsection (c); and
                            ``(v) meets such additional requirements as 
                        the Secretary may find necessary.
                    ``(B) Opioid use disorder treatment services.--The 
                term `opioid use disorder treatment services' means 
                items and services that are furnished by an opioid 
                treatment program for the treatment of opioid use 
                disorder, including--
                            ``(i) opioid agonist and antagonist 
                        treatment medications (including oral, 
                        injected, or implanted versions) that are 
                        approved by the Food and Drug Administration 
                        under section 505 of the Federal Food, Drug and 
                        Cosmetic Act for use in the treatment of opioid 
                        use disorder;
                            ``(ii) dispensing and administration of 
                        such medications, if applicable;
                            ``(iii) substance use counseling by a 
                        professional to the extent authorized under 
                        State law to furnish such services;
                            ``(iv) individual and group therapy with a 
                        physician or psychologist (or other mental 
                        health professional to the extent authorized 
                        under State law);
                            ``(v) toxicology testing; and
                            ``(vi) other items and services that the 
                        Secretary determines are appropriate (but in no 
                        case to include meals or transportation).
            ``(3) Bundled payment under part b.--
                    ``(A) In general.--The Secretary shall pay, from 
                the Federal Supplementary Medical Insurance Trust Fund 
                under section 1841, to an opioid treatment program 
                participating in the demonstration a bundled payment as 
                determined by the Secretary for opioid use disorder 
                treatment services that are furnished by such treatment 
                program to an individual under part B during an episode 
                of care (as defined by the Secretary).
                    ``(B) Considerations.--The Secretary may implement 
                this paragraph through one or more bundles based on the 
                type of medication provided (such as buprenorphine, 
                methadone, naltrexone, or a new innovative drug), the 
                frequency of services furnished, the scope of services 
                furnished, characteristics of the individuals furnished 
                such services, or other factors as the Secretary 
                determine appropriate. In developing such bundles, the 
                Secretary may consider payment rates paid to opioid 
                treatment programs for comparable services under State 
                plans under title XIX or under the TRICARE program 
                under chapter 55 of title 10 of the United States Code.
    ``(b) Implementation.--
            ``(1) Duration.--The demonstration shall be conducted for a 
        period of 5 years, beginning not later than January 1, 2021.
            ``(2) Scope.--In carrying out the demonstration, the 
        Secretary shall limit the number of beneficiaries that may 
        participate at any one time in the demonstration to 2,000.
            ``(3) Waiver.--The Secretary may waive such provisions of 
        this title and title XI as the Secretary determines necessary 
        in order to implement the demonstration.
            ``(4) Administration.--Chapter 35 of title 44, United 
        States Code, shall not apply to this section.
    ``(c) Evaluation and Report.--
            ``(1) Evaluation.--The Secretary shall conduct an 
        evaluation of the demonstration. Such evaluation shall include 
        analyses of--
                    ``(A) the impact of the demonstration on--
                            ``(i) utilization of health care items and 
                        services related to opioid use disorder, 
                        including hospitalizations and emergency 
                        department visits;
                            ``(ii) beneficiary health outcomes related 
                        to opioid use disorder, including opioid 
                        overdose deaths; and
                            ``(iii) overall expenditures under this 
                        title; and
                    ``(B) the performance of opioid treatment programs 
                participating in the demonstration with respect to 
                applicable quality and cost metrics, including whether 
                any additional quality measures related to opioid use 
                disorder treatment are needed with respect to such 
                programs under this title.
            ``(2) Report.--Not later than 2 years after the completion 
        of the demonstration, the Secretary shall submit to Congress a 
        report containing the results of the evaluation conducted under 
        paragraph (1), together with recommendations for such 
        legislation and administrative action as the Secretary 
        determines appropriate.
    ``(d) Funding.--For purposes of administering and carrying out the 
demonstration, in addition to funds otherwise appropriated, there shall 
be transferred to the Secretary for the Center for Medicare & Medicaid 
Services Program Management Account from the Federal Supplementary 
Medical Insurance Trust Fund under section 1841 $5,000,000, to remain 
available until expended.''.

SEC. 110. ENCOURAGING APPROPRIATE PRESCRIBING UNDER MEDICARE FOR 
              VICTIMS OF OPIOID OVERDOSE.

    Section 1860D-4(c)(5)(C) of the Social Security Act (42 U.S.C. 
1395w-104(c)(5)(C)) is amended--
            (1) in clause (i), in the matter preceding subclause (I), 
        by striking ``For purposes'' and inserting ``Except as provided 
        in clause (v), for purposes''; and
            (2) by adding at the end the following new clause:
                            ``(v) Treatment of enrollees with a history 
                        of opioid-related overdose.--
                                    ``(I) In general.--For plan years 
                                beginning not later than January 1, 
                                2021, a part D eligible individual who 
                                is not an exempted individual described 
                                in clause (ii) and who is identified 
                                under this clause as a part D eligible 
                                individual with a history of opioid-
                                related overdose (as defined by the 
                                Secretary) shall be included as a 
                                potentially at-risk beneficiary for 
                                prescription drug abuse under the drug 
                                management program under this 
                                paragraph.
                                    ``(II) Identification and notice.--
                                For purposes of this clause, the 
                                Secretary shall--
                                            ``(aa) identify part D 
                                        eligible individuals with a 
                                        history of opioid-related 
                                        overdose (as so defined); and
                                            ``(bb) notify the PDP 
                                        sponsor of the prescription 
                                        drug plan in which such an 
                                        individual is enrolled of such 
                                        identification.''.

SEC. 111. AUTOMATIC ESCALATION TO EXTERNAL REVIEW UNDER A MEDICARE PART 
              D DRUG MANAGEMENT PROGRAM FOR AT-RISK BENEFICIARIES.

    (a) In General.--Section 1860D-4(c)(5) of the Social Security Act 
(42 U.S.C. 1395ww-10(c)(5)) is amended--
            (1) in subparagraph (B), in each of clauses (ii)(III) and 
        (iii)(IV), by striking ``and the option of an automatic 
        escalation to external review'' and inserting ``, including 
        notice that if on reconsideration a PDP sponsor affirms its 
        denial, in whole or in part, the case shall be automatically 
        forwarded to the independent, outside entity contracted with 
        the Secretary for review and resolution''; and
            (2) in subparagraph (E), by striking ``and the option'' and 
        all that follows and inserting the following: ``and if on 
        reconsideration a PDP sponsor affirms its denial, in whole or 
        in part, the case shall be automatically forwarded to the 
        independent, outside entity contracted with the Secretary for 
        review and resolution.''.
    (b) Effective Date.--The amendments made by subsection (a) shall 
apply beginning not later January 1, 2021.

SEC. 112. MEDICARE IMPROVEMENT FUND.

    Section 1898(b)(1) of the Social Security Act (42 U.S.C. 
1395iii(b)(1)) is amended by striking ``fiscal year 2021, $0'' and 
inserting ``fiscal year 2023, $50,000,000''.

                           TITLE II--MEDICAID

SEC. 201. CARING RECOVERY FOR INFANTS AND BABIES.

    (a) State Plan Amendment.--Section 1902(a) of the Social Security 
Act (42 U.S.C. 1396a(a)) is amended--
            (1) in paragraph (82), by striking ``and'' after the 
        semicolon;
            (2) in paragraph (83), by striking the period at the end 
        and inserting ``; and''; and
            (3) by inserting after paragraph (83), the following new 
        paragraph:
            ``(84) provide, at the option of the State, for making 
        medical assistance available on an inpatient or outpatient 
        basis at a residential pediatric recovery center (as defined in 
        subsection (nn)) to infants with neonatal abstinence 
        syndrome.''.
    (b) Residential Pediatric Recovery Center Defined.--Section 1902 of 
such Act (42 U.S.C. 1396a) is amended by adding at the end the 
following new subsection:
    ``(nn) Residential Pediatric Recovery Center Defined.--
            ``(1) In general.--For purposes of section 1902(a)(84), the 
        term `residential pediatric recovery center' means a center or 
        facility that furnishes items and services for which medical 
        assistance is available under the State plan to infants with 
        the diagnosis of neonatal abstinence syndrome without any other 
        significant medical risk factors.
            ``(2) Counseling and services.--A residential pediatric 
        recovery center may offer counseling and other services to 
        mothers (and other appropriate family members and caretakers) 
        of infants receiving treatment at such centers if such services 
        are otherwise covered under the State plan under this title or 
        under a waiver of such plan. Such other services may include 
        the following:
                    ``(A) Counseling or referrals for services.
                    ``(B) Activities to encourage caregiver-infant 
                bonding.
                    ``(C) Training on caring for such infants.''.
    (c) Effective Date.--The amendments made by this section take 
effect on the date of enactment of this Act and shall apply to medical 
assistance furnished on or after that date, without regard to final 
regulations to carry out such amendments being promulgated as of such 
date.

SEC. 202. PEER SUPPORT ENHANCEMENT AND EVALUATION REVIEW.

    (a) In General.--Not later than 2 years after the date of the 
enactment of this Act, the Comptroller General of the United States 
shall submit to the Committee on Energy and Commerce of the House of 
Representatives, the Committee on Finance of the Senate, and the 
Committee on Health, Education, Labor, and Pensions of the Senate a 
report on the provision of peer support services under the Medicaid 
program.
    (b) Content of Report.--
            (1) In general.--The report required under subsection (a) 
        shall include the following information:
                    (A) Information on State coverage of peer support 
                services under Medicaid, including--
                            (i) the mechanisms through which States may 
                        provide such coverage, including through 
                        existing statutory authority or through 
                        waivers;
                            (ii) the populations to which States have 
                        provided such coverage;
                            (iii) the payment models, including any 
                        alternative payment models, used by States to 
                        pay providers of such services; and
                            (iv) where available, information on 
                        Federal and State spending under Medicaid for 
                        peer support services.
                    (B) Information on selected State experiences in 
                providing medical assistance for peer support services 
                under State Medicaid plans and whether States measure 
                the effects of providing such assistance with respect 
                to--
                            (i) improving access to behavioral health 
                        services;
                            (ii) improving early detection, and 
                        preventing worsening, of behavioral health 
                        disorders;
                            (iii) reducing chronic and comorbid 
                        conditions; and
                            (iv) reducing overall health costs.
            (2) Recommendations.--The report required under subsection 
        (a) shall include recommendations, including recommendations 
        for such legislative and administrative actions related to 
        improving services, including peer support services, and access 
        to peer support services under Medicaid as the Comptroller 
        General of the United States determines appropriate.

SEC. 203. MEDICAID SUBSTANCE USE DISORDER TREATMENT VIA TELEHEALTH.

    (a) Definitions.--In this section:
            (1) Comptroller general.--The term ``Comptroller General'' 
        means the Comptroller General of the United States.
            (2) School-based health center.--The term ``school-based 
        health center'' has the meaning given that term in section 
        2110(c)(9) of the Social Security Act (42 U.S.C. 1397jj(c)(9)).
            (3) Secretary.--The term ``Secretary'' means the Secretary 
        of Health and Human Services.
            (4) Teleheath services.--The term ``telehealth services'' 
        includes remote patient monitoring and other key modalities 
        such as live video or synchronous telehealth, store-and-forward 
        or asynchronous telehealth, mobile health, telephonic 
        consultation, and electronic consult including provider-to-
        provider e-consults.
            (5) Underserved area.--The term ``underserved area'' means 
        a health professional shortage area (as defined in section 
        332(a)(1)(A) of the Public Health Service Act (42 U.S.C. 
        254e(a)(1)(A))) and a medically underserved area (according to 
        a designation under section 330(b)(3)(A) of the Public Health 
        Service Act (42 U.S.C. 254b(b)(3)(A))).
    (b) Guidance to States Regarding Federal Reimbursement for 
Furnishing Services and Treatment for Substance Use Disorders Under 
Medicaid Using Telehealth Services, Including in School-based Health 
Centers.--Not later than 1 year after the date of enactment of this 
Act, the Secretary, acting through the Administrator of the Centers for 
Medicare & Medicaid Services, shall issue guidance to States on the 
following:
            (1) State options for Federal reimbursement of expenditures 
        under Medicaid for furnishing services and treatment for 
        substance use disorders, including assessment, medication-
        assisted treatment, counseling, and medication management, 
        using telehealth services. Such guidance shall also include 
        guidance on furnishing services and treatments that address the 
        needs of high risk individuals, including at least the 
        following groups:
                    (A) American Indians and Alaska Natives.
                    (B) Adults under the age of 40.
                    (C) Individuals with a history of nonfatal 
                overdose.
            (2) State options for Federal reimbursement of expenditures 
        under Medicaid for education directed to providers serving 
        Medicaid beneficiaries with substance use disorders using the 
        hub and spoke model, through contracts with managed care 
        entities, through administrative claiming for disease 
        management activities, and under Delivery System Reform 
        Incentive Payment (``DSRIP'') programs.
            (3) State options for Federal reimbursement of expenditures 
        under Medicaid for furnishing services and treatment for 
        substance use disorders for individuals enrolled in Medicaid in 
        a school-based health center using telehealth services.
    (c) GAO Evaluation of Children's Access to Services and Treatment 
for Substance Use Disorders Under Medicaid.--
            (1) Study.--The Comptroller General shall evaluate 
        children's access to services and treatment for substance use 
        disorders under Medicaid. The evaluation shall include an 
        analysis of State options for improving children's access to 
        such services and treatment and for improving outcomes, 
        including by increasing the number of Medicaid providers who 
        offer services or treatment for substance use disorders in a 
        school-based health center using telehealth services, 
        particularly in rural and underserved areas. The evaluation 
        shall include an analysis of Medicaid provider reimbursement 
        rates for services and treatment for substance use disorders.
            (2) Report.--Not later than 1 year after the date of 
        enactment of this Act, the Comptroller General shall submit to 
        Congress a report containing the results of the evaluation 
        conducted under paragraph (1), together with recommendations 
        for such legislation and administrative action as the 
        Comptroller General determines appropriate.
    (d) Report on Reducing Barriers to Using Telehealth Services and 
Remote Patient Monitoring for Pediatric Populations Under Medicaid.--
            (1) In general.--Not later than 1 year after the date of 
        enactment of this Act, the Secretary, acting through the 
        Administrator of the Centers for Medicare & Medicaid Services, 
        shall issue a report to the Committee on Finance of the Senate 
        and the Committee on Energy and Commerce of the House of 
        Representative identifying best practices and potential 
        solutions for reducing barriers to using telehealth services to 
        furnish services and treatment for substance use disorders 
        among pediatric populations under Medicaid. The report shall 
        include--
                    (A) analyses of the best practices, barriers, and 
                potential solutions for using telehealth services to 
                diagnose and provide services and treatment for 
                children with substance use disorders, including opioid 
                use disorder; and
                    (B) identification and analysis of the differences, 
                if any, in furnishing services and treatment for 
                children with substance use disorders using telehealth 
                services and using services delivered in person, such 
                as, and to the extent feasible, with respect to--
                            (i) utilization rates;
                            (ii) costs;
                            (iii) avoidable inpatient admissions and 
                        readmissions;
                            (iv) quality of care; and
                            (v) patient, family, and provider 
                        satisfaction.
            (2) Publication.--The Secretary shall publish the report 
        required under paragraph (1) on a public Internet website of 
        the Department of Health and Human Services.

SEC. 204. ENHANCING PATIENT ACCESS TO NON-OPIOID TREATMENT OPTIONS.

    Not later than January 1, 2019, the Secretary of Health and Human 
Services, acting through the Administrator of the Centers for Medicare 
& Medicaid Services, shall issue 1 or more final guidance documents, or 
update existing guidance documents, to States regarding mandatory and 
optional items and services that may be provided under a State plan 
under title XIX of the Social Security Act (42 U.S.C. 1396 et seq.), or 
under a waiver of such a plan, for non-opioid treatment and management 
of pain, including, but not limited to, evidence-based non-opioid 
pharmacological therapies and non-pharmacological therapies.

SEC. 205. ASSESSING BARRIERS TO OPIOID USE DISORDER TREATMENT.

    (a) Study.--
            (1) In general.--The Comptroller General of the United 
        States (in this section referred to as the ``Comptroller 
        General'') shall conduct a study regarding the barriers to 
        providing medication used in the treatment of substance use 
        disorders under Medicaid distribution models such as the ``buy-
        and-bill'' model, and options for State Medicaid programs to 
        remove or reduce such barriers. The study shall include 
        analyses of each of the following models of distribution of 
        substance use disorder treatment medications, particularly 
        buprenorphine, naltrexone, and buprenorphine-naloxone 
        combinations:
                    (A) The purchasing, storage, and administration of 
                substance use disorder treatment medications by 
                providers.
                    (B) The dispensing of substance use disorder 
                treatment medications by pharmacists.
                    (C) The ordering, prescribing, and obtaining 
                substance use disorder treatment medications on demand 
                from specialty pharmacies by providers.
            (2) Requirements.--For each model of distribution specified 
        in paragraph (1), the Comptroller General shall evaluate how 
        each model presents barriers or could be used by selected State 
        Medicaid programs to reduce the barriers related to the 
        provision of substance use disorder treatment by examining what 
        is known about the effects of the model of distribution on--
                    (A) Medicaid beneficiaries' access to substance use 
                disorder treatment medications;
                    (B) the differential cost to the program between 
                each distribution model for medication assisted 
                treatment; and
                    (C) provider willingness to provide or prescribe 
                substance use disorder treatment medications.
    (b) Report.--Not later than 15 months after the date of the 
enactment of this Act, the Comptroller General shall submit to Congress 
a report containing the results of the study conducted under subsection 
(a), together with recommendations for such legislation and 
administrative action as the Comptroller General determines 
appropriate.

SEC. 206. HELP FOR MOMS AND BABIES.

    (a) Medicaid State Plan.--Section 1905(a) of the Social Security 
Act (42 U.S.C. 1396d(a)) is amended by adding at the end the following 
new sentence: ``In the case of a woman who is eligible for medical 
assistance on the basis of being pregnant (including through the end of 
the month in which the 60-day period beginning on the last day of her 
pregnancy ends), who is a patient in an institution for mental diseases 
for purposes of receiving treatment for a substance use disorder, and 
who was enrolled for medical assistance under the State plan 
immediately before becoming a patient in an institution for mental 
diseases or who becomes eligible to enroll for such medical assistance 
while such a patient, the exclusion from the definition of `medical 
assistance' set forth in the subdivision (B) following paragraph (29) 
of the first sentence of this subsection shall not be construed as 
prohibiting Federal financial participation for medical assistance for 
items or services that are provided to the woman outside of the 
institution.''.
    (b) Effective Date.--
            (1) In general.--Except as provided in paragraph (2), the 
        amendment made by subsection (a) shall take effect on the date 
        of enactment of this Act.
            (2) Rule for changes requiring state legislation.--In the 
        case of a State plan under title XIX of the Social Security Act 
        which the Secretary of Health and Human Services determines 
        requires State legislation (other than legislation 
        appropriating funds) in order for the plan to meet the 
        additional requirements imposed by the amendment made by 
        subsection (a), the State plan shall not be regarded as failing 
        to comply with the requirements of such title solely on the 
        basis of its failure to meet these additional requirements 
        before the first day of the first calendar quarter beginning 
        after the close of the first regular session of the State 
        legislature that begins after the date of the enactment of this 
        Act. For purposes of the previous sentence, in the case of a 
        State that has a 2-year legislative session, each year of such 
        session shall be deemed to be a separate regular session of the 
        State legislature.

SEC. 207. SECURING FLEXIBILITY TO TREAT SUBSTANCE USE DISORDERS.

    Section 1903(m) of the Social Security Act (42 U.S.C. 1396b(m)) is 
amended by adding at the end the following new paragraph:
    ``(7) Payment shall be made under this title to a State for 
expenditures for capitation payments described in section 438.6(e) of 
title 42, Code of Federal Regulations (or any successor regulation).''.

SEC. 208. MACPAC STUDY AND REPORT ON MAT UTILIZATION CONTROLS UNDER 
              STATE MEDICAID PROGRAMS.

    (a) Study.--The Medicaid and CHIP Payment and Access Commission 
shall conduct a study and analysis of utilization control policies 
applied to medication-assisted treatment for substance use disorders 
under State Medicaid programs, including policies and procedures 
applied both in fee-for-service Medicaid and in risk-based managed care 
Medicaid, which shall--
            (1) include an inventory of such utilization control 
        policies and related protocols for ensuring access to medically 
        necessary treatment;
            (2) determine whether managed care utilization control 
        policies and procedures for medication assisted treatment for 
        substance use disorders are consistent with section 
        438.210(a)(4)(ii) of title 42, Code of Federal Regulations; and
            (3) identify policies that--
                    (A) limit an individual's access to medication-
                assisted treatment for a substance use disorder by 
                limiting the quantity of medication-assisted treatment 
                prescriptions, or the number of refills for such 
                prescriptions, available to the individual as part of a 
                prior authorization process or similar utilization 
                protocols; and
                    (B) apply without evaluating individual instances 
                of fraud, waste, or abuse.
    (b) Report.--Not later than 1 year after the date of the enactment 
of this Act, the Medicaid and CHIP Payment and Access Commission shall 
make publicly available a report containing the results of the study 
conducted under subsection (a).

SEC. 209. OPIOID ADDICTION TREATMENT PROGRAMS ENHANCEMENT.

    (a) T-MSIS Substance Use Disorder Data Book.--
            (1) In general.--Not later than the date that is 12 months 
        after the date of enactment of this Act, the Secretary of 
        Health and Human Services (in this section referred to as the 
        ``Secretary'') shall publish on the public website of the 
        Centers for Medicare & Medicaid Services a report with 
        comprehensive data on the prevalence of substance use disorders 
        in the Medicaid beneficiary population and services provided 
        for the treatment of substance use disorders under Medicaid.
            (2) Content of report.--The report required under paragraph 
        (1) shall include, at a minimum, the following data for each 
        State (including, to the extent available, for the District of 
        Columbia, Puerto Rico, the Virgin Islands, Guam, the Northern 
        Mariana Islands, and American Samoa):
                    (A) The number and percentage of individuals 
                enrolled in the State Medicaid plan or waiver of such 
                plan in each of the major enrollment categories (as 
                defined in a public letter from the Medicaid and CHIP 
                Payment and Access Commission to the Secretary) who 
                have been diagnosed with a substance use disorder and 
                whether such individuals are enrolled under the State 
                Medicaid plan or a waiver of such plan, including the 
                specific waiver authority under which they are 
                enrolled, to the extent available.
                    (B) A list of the substance use disorder treatment 
                services by each major type of service, such as 
                counseling, medication assisted treatment, peer 
                support, residential treatment, and inpatient care, for 
                which beneficiaries in each State received at least 1 
                service under the State Medicaid plan or a waiver of 
                such plan.
                    (C) The number and percentage of individuals with a 
                substance use disorder diagnosis enrolled in the State 
                Medicaid plan or waiver of such plan who received 
                substance use disorder treatment services under such 
                plan or waiver by each major type of service under 
                subparagraph (B) within each major setting type, such 
                as outpatient, inpatient, residential, and other home 
                and community-based settings.
                    (D) The number of services provided under the State 
                Medicaid plan or waiver of such plan per individual 
                with a substance use disorder diagnosis enrolled in 
                such plan or waiver for each major type of service 
                under subparagraph (B).
                    (E) The number and percentage of individuals 
                enrolled in the State Medicaid plan or waiver, by major 
                enrollment category, who received substance use 
                disorder treatment through--
                            (i) a medicaid managed care entity (as 
                        defined in section 1932(a)(1)(B) of the Social 
                        Security Act (42 U.S.C. 1396u-2(a)(1)(B))), 
                        including the number of such individuals who 
                        received such assistance through a prepaid 
                        inpatient health plan or a prepaid ambulatory 
                        health plan;
                            (ii) a fee-for-service payment model; or
                            (iii) an alternative payment model, to the 
                        extent available.
                    (F) The number and percentage of individuals with a 
                substance use disorder who receive substance use 
                disorder treatment services in an outpatient or home 
                and community-based setting after receiving treatment 
                in an inpatient or residential setting, and the number 
                of services received by such individuals in the 
                outpatient or home and community-based setting.
            (3) Annual updates.--The Secretary shall issue an updated 
        version of the report required under paragraph (1) not later 
        than January 1 of each calendar year through 2024.
            (4) Use of t-msis data.--The report required under 
        paragraph (1) and updates required under paragraph (3) shall--
                    (A) use data and definitions from the Transformed 
                Medicaid Statistical Information System (``T-MSIS'') 
                data set that is no more than 12 months old on the date 
                that the report or update is published; and
                    (B) as appropriate, include a description with 
                respect to each State of the quality and completeness 
                of the data and caveats describing the limitations of 
                the data reported to the Secretary by the State that is 
                sufficient to communicate the appropriate uses for the 
                information.
    (b) Making T-MSIS Data on Substance Use Disorders Available to 
Researchers.--
            (1) In general.--The Secretary shall publish in the Federal 
        Register a system of records notice for the data specified in 
        paragraph (2) for the Transformed Medicaid Statistical 
        Information System, in accordance with section 552a(e)(4) of 
        title 5, United States Code. The notice shall outline policies 
        that protect the security and privacy of the data that, at a 
        minimum, meet the security and privacy policies of SORN 09-70-
        0541 for the Medicaid Statistical Information System.
            (2) Required data.--The data covered by the systems of 
        records notice required under paragraph (1) shall be sufficient 
        for researchers and States to analyze the prevalence of 
        substance use disorders in the Medicaid beneficiary population 
        and the treatment of substance use disorders under Medicaid 
        across all States (including the District of Columbia, Puerto 
        Rico, the Virgin Islands, Guam, the Northern Mariana Islands, 
        and American Samoa), forms of treatment, and treatment 
        settings.
            (3) Initiation of data-sharing activities.--Not later than 
        January 1, 2019, the Secretary shall initiate the data-sharing 
        activities outlined in the notice required under paragraph (1).

SEC. 210. BETTER DATA SHARING TO COMBAT THE OPIOID CRISIS.

    (a) In General.--Section 1903(m) of the Social Security Act (42 
U.S.C. 1396b(m)), as amended by section 207, is amended by adding at 
the end the following new paragraph:
    ``(8)(A) The State agency administering the State plan under this 
title may have reasonable access, as determined by the State, to 1 or 
more prescription drug monitoring program databases administered or 
accessed by the State to the extent the State agency is permitted to 
access such databases under State law.
    ``(B) Such State agency may facilitate reasonable access, as 
determined by the State, to 1 or more prescription drug monitoring 
program databases administered or accessed by the State, to same extent 
that the State agency is permitted under State law to access such 
databases, for--
            ``(i) any provider enrolled under the State plan to provide 
        services to Medicaid beneficiaries; and
            ``(ii) any managed care entity (as defined under section 
        1932(a)(1)(B)) that has a contract with the State under this 
        subsection or under section 1905(t)(3).
    ``(C) Such State agency may share information in such databases, to 
the same extent that the State agency is permitted under State law to 
share information in such databases, with--
            ``(i) any provider enrolled under the State plan to provide 
        services to Medicaid beneficiaries; and
            ``(ii) any managed care entity (as defined under section 
        1932(a)(1)(B)) that has a contract with the State under this 
        subsection or under section 1905(t)(3).''.
    (b) Security and Privacy.--All applicable State and Federal 
security and privacy protections and laws shall apply to any State 
agency, individual, or entity accessing 1 or more prescription drug 
monitoring program databases or obtaining information in such databases 
in accordance with section 1903(m)(8) of the Social Security Act (42 
U.S.C. 1396b(m)(8)) (as added by subsection (a)).
    (c) Effective Date.--The amendment made by subsection (a) shall 
take effect on the date of enactment of this Act.

SEC. 211. MANDATORY REPORTING WITH RESPECT TO ADULT BEHAVIORAL HEALTH 
              MEASURES.

    Section 1139B of the Social Security Act (42 U.S.C. 1320b-9b) is 
amended--
            (1) in subsection (b)--
                    (A) in paragraph (3)--
                            (i) by striking ``Not later than January 1, 
                        2013'' and inserting the following:
                    ``(A) Voluntary reporting.--Not later than January 
                1, 2013''; and
                            (ii) by adding at the end the following:
                    ``(B) Mandatory reporting with respect to 
                behavioral health measures.--Beginning with the State 
                report required under subsection (d)(1) for 2024, the 
                Secretary shall require States to use all behavioral 
                health measures included in the core set of adult 
                health quality measures and any updates or changes to 
                such measures to report information, using the 
                standardized format for reporting information and 
                procedures developed under subparagraph (A), regarding 
                the quality of behavioral health care for Medicaid 
                eligible adults.'';
                    (B) in paragraph (5), by adding at the end the 
                following new subparagraph:
                    ``(C) Behavioral health measures.--Beginning with 
                respect to State reports required under subsection 
                (d)(1) for 2024, the core set of adult health quality 
                measures maintained under this paragraph (and any 
                updates or changes to such measures) shall include 
                behavioral health measures.''; and
            (2) in subsection (d)(1)(A)--
                    (A) by striking ``the such plan'' and inserting 
                ``such plan''; and
                    (B) by striking ``subsection (a)(5)'' and inserting 
                ``subsection (b)(5) and, beginning with the report for 
                2024, all behavioral health measures included in the 
                core set of adult health quality measures maintained 
                under such subsection (b)(5) and any updates or changes 
                to such measures (as required under subsection 
                (b)(3))''.

SEC. 212. REPORT ON INNOVATIVE STATE INITIATIVES AND STRATEGIES TO 
              PROVIDE HOUSING-RELATED SERVICES AND SUPPORTS TO 
              INDIVIDUALS STRUGGLING WITH SUBSTANCE USE DISORDERS UNDER 
              MEDICAID.

    (a) In General.--Not later than 1 year after the date of enactment 
of this Act, the Secretary of Health and Human Services shall issue a 
report to Congress describing innovative State initiatives and 
strategies for providing housing-related services and supports under a 
State Medicaid program to individuals with substance use disorders who 
are experiencing or at risk of experiencing homelessness.
    (b) Content of Report.--The report required under subsection (a) 
shall describe the following:
            (1) Existing methods and innovative strategies developed 
        and adopted by State Medicaid programs that have achieved 
        positive outcomes in increasing housing stability among 
        Medicaid beneficiaries with substance use disorders who are 
        experiencing or at risk of experiencing homelessness, including 
        Medicaid beneficiaries with substance use disorders who are--
                    (A) receiving treatment for substance use disorders 
                in inpatient, residential, outpatient, or home and 
                community-based settings;
                    (B) transitioning between substance use disorder 
                treatment settings; or
                    (C) living in supportive housing or another model 
                of affordable housing.
            (2) Strategies employed by Medicaid managed care 
        organizations, primary care case managers, hospitals, 
        accountable care organizations, and other care coordination 
        providers to deliver housing-related services and supports and 
        to coordinate services provided under State Medicaid programs 
        across different treatment settings.
            (3) Innovative strategies and lessons learned by States 
        with Medicaid waivers approved under section 1115 or 1915 of 
        the Social Security Act (42 U.S.C. 1315, 1396n), including--
                    (A) challenges experienced by States in designing, 
                securing, and implementing such waivers or plan 
                amendments;
                    (B) how States developed partnerships with other 
                organizations such as behavioral health agencies, State 
                housing agencies, housing providers, health care 
                services agencies and providers, community-based 
                organizations, and health insurance plans to implement 
                waivers or State plan amendments; and
                    (C) how and whether States plan to provide Medicaid 
                coverage for housing-related services and supports in 
                the future, including by covering such services and 
                supports under State Medicaid plans or waivers.
            (4) Existing opportunities for States to provide housing-
        related services and supports through a Medicaid waiver under 
        sections 1115 or 1915 of the Social Security Act (42 U.S.C. 
        1315, 1396n) or through a State Medicaid plan amendment, such 
        as the Assistance in Community Integration Service pilot 
        program, which promotes supportive housing and other housing-
        related supports under Medicaid for individuals with substance 
        use disorders and for which Maryland has a waiver approved 
        under such section 1115 to conduct the program.
            (5) Innovative strategies and partnerships developed and 
        implemented by State Medicaid programs or other entities to 
        identify and enroll eligible individuals with substance use 
        disorders who are experiencing or at risk of experiencing 
        homelessness in State Medicaid programs.

SEC. 213. TECHNICAL ASSISTANCE AND SUPPORT FOR INNOVATIVE STATE 
              STRATEGIES TO PROVIDE HOUSING-RELATED SUPPORTS UNDER 
              MEDICAID.

    (a) In General.--The Secretary of Health and Human Services shall 
provide technical assistance and support to States regarding the 
development and expansion of innovative State strategies (including 
through State Medicaid demonstration projects) to provide housing-
related supports and services and care coordination services under 
Medicaid to individuals with substance use disorders.
    (b) Report.--Not later than 180 days after the date of enactment of 
this Act, the Secretary shall issue a report to Congress detailing a 
plan of action to carry out the requirements of subsection (a).

                       TITLE III--HUMAN SERVICES

SEC. 301. SUPPORTING FAMILY-FOCUSED RESIDENTIAL TREATMENT.

    (a) Definitions.--In this section:
            (1) Family-focused residential treatment program.--The term 
        ``family-focused residential treatment program'' means a 
        trauma-informed residential program primarily for substance use 
        disorder treatment for pregnant and postpartum women and 
        parents and guardians that allows children to reside with such 
        women or their parents or guardians during treatment to the 
        extent appropriate and applicable.
            (2) Medicaid program.--The term ``Medicaid program'' means 
        the program established under title XIX of the Social Security 
        Act (42 U.S.C. 1396 et seq.).
            (3) Secretary.--The term ``Secretary'' means the Secretary 
        of Health and Human Services.
            (4) Title iv-e program.--The term ``title IV-E program'' 
        means the program for foster care, prevention, and permanency 
        established under part E of title IV of the Social Security Act 
        (42 U.S.C. 670 et seq.).
    (b) Guidance on Family-focused Residential Treatment Programs.--
            (1) In general.--Not later than 180 days after the date of 
        enactment of this Act, the Secretary, in consultation with 
        divisions of the Department of Health and Human Services 
        administering substance use disorder or child welfare programs, 
        shall develop and issue guidance to States identifying 
        opportunities to support family-focused residential treatment 
        programs for the provision of substance use disorder treatment. 
        Before issuing such guidance, the Secretary shall solicit input 
        from representatives of States, health care providers with 
        expertise in addiction medicine, obstetrics and gynecology, 
        neonatology, child trauma, and child development, health plans, 
        recipients of family-focused treatment services, and other 
        relevant stakeholders.
            (2) Additional requirements.--The guidance required under 
        paragraph (1) shall include descriptions of the following:
                    (A) Existing opportunities and flexibilities under 
                the Medicaid program, including under waivers 
                authorized under section 1115 or 1915 of the Social 
                Security Act (42 U.S.C. 1315, 1396n), for States to 
                receive Federal Medicaid funding for the provision of 
                substance use disorder treatment for pregnant and 
                postpartum women and parents and guardians and, to the 
                extent applicable, their children, in family-focused 
                residential treatment programs.
                    (B) How States can employ and coordinate funding 
                provided under the Medicaid program, the title IV-E 
                program, and other programs administered by the 
                Secretary to support the provision of treatment and 
                services provided by a family-focused residential 
                treatment facility such as substance use disorder 
                treatment and services, including medication-assisted 
                treatment, family, group, and individual counseling, 
                case management, parenting education and skills 
                development, the provision, assessment, or coordination 
                of care and services for children, including necessary 
                assessments and appropriate interventions, non-
                emergency transportation for necessary care provided at 
                or away from a program site, transitional services and 
                supports for families leaving treatment, and other 
                services.
                    (C) How States can employ and coordinate funding 
                provided under the Medicaid program and the title IV-E 
                program (including as amended by the Family First 
                Prevention Services Act enacted under title VII of 
                division E of Public Law 115-123, and particularly with 
                respect to the authority under subsections (a)(2)(C) 
                and (j) of section 472 and section 474(a)(1) of the 
                Social Security Act (42 U.S.C. 672, 674(a)(1)) (as 
                amended by section 50712 of Public Law 115-123) to 
                provide foster care maintenance payments for a child 
                placed with a parent who is receiving treatment in a 
                licensed residential family-based treatment facility 
                for a substance use disorder) to support placing 
                children with their parents in family-focused 
                residential treatment programs.

SEC. 302. IMPROVING RECOVERY AND REUNIFYING FAMILIES.

    Section 435 of the Social Security Act (42 U.S.C. 629e) is amended 
by adding at the end the following:
    ``(e) Family Recovery and Reunification Program Replication 
Project.--
            ``(1) Purpose.--The purpose of this subsection is to 
        provide resources to the Secretary to support the conduct and 
        evaluation of a family recovery and reunification program 
        replication project (referred to in this subsection as the 
        `project') and to determine the extent to which such programs 
        may be appropriate for use at different intervention points 
        (such as when a child is at risk of entering foster care or 
        when a child is living with a guardian while a parent is in 
        treatment). The family recovery and reunification program 
        conducted under the project shall use a recovery coach model 
        that is designed to help reunify families and protect children 
        by working with parents or guardians with a substance use 
        disorder who have temporarily lost custody of their children.
            ``(2) Program components.--The family recovery and 
        reunification program conducted under the project shall adhere 
        closely to the elements and protocol determined to be most 
        effective in other recovery coaching programs that have been 
        rigorously evaluated and shown to increase family reunification 
        and protect children and, consistent with such elements and 
        protocol, shall provide such items and services as--
                    ``(A) assessments to evaluate the needs of the 
                parent or guardian;
                    ``(B) assistance in receiving the appropriate 
                benefits to aid the parent or guardian in recovery;
                    ``(C) services to assist the parent or guardian in 
                prioritizing issues identified in assessments, 
                establishing goals for resolving such issues that are 
                consistent with the goals of the treatment provider, 
                child welfare agency, courts, and other agencies 
                involved with the parent or guardian or their children, 
                and making a coordinated plan for achieving such goals;
                    ``(D) home visiting services coordinated with the 
                child welfare agency and treatment provider involved 
                with the parent or guardian or their children;
                    ``(E) case management services to remove barriers 
                for the parent or guardian to participate and continue 
                in treatment, as well as to re-engage a parent or 
                guardian who is not participating or progressing in 
                treatment;
                    ``(F) access to services needed to monitor the 
                parent's or guardian's compliance with program 
                requirements;
                    ``(G) frequent reporting between the treatment 
                provider, child welfare agency, courts, and other 
                agencies involved with the parent or guardian or their 
                children to ensure appropriate information on the 
                parent's or guardian's status is available to inform 
                decision-making; and
                    ``(H) assessments and recommendations provided by a 
                recovery coach to the child welfare caseworker 
                responsible for documenting the parent's or guardian's 
                progress in treatment and recovery as well as the 
                status of other areas identified in the treatment plan 
                for the parent or guardian, including a recommendation 
                regarding the expected safety of the child if the child 
                is returned to the custody of the parent or guardian 
                that can be used by the caseworker and a court to make 
                permanency decisions regarding the child.
            ``(3) Responsibilities of the secretary.--
                    ``(A) In general.--The Secretary shall, through a 
                grant or contract with 1 or more entities, conduct and 
                evaluate the family recovery and reunification program 
                under the project.
                    ``(B) Requirements.--In identifying 1 or more 
                entities to conduct the evaluation of the family 
                recovery and reunification program, the Secretary 
                shall--
                            ``(i) determine that the area or areas in 
                        which the program will be conducted have 
                        sufficient substance use disorder treatment 
                        providers and other resources (other than those 
                        provided with funds made available to carry out 
                        the project) to successfully conduct the 
                        program;
                            ``(ii) determine that the area or areas in 
                        which the program will be conducted have enough 
                        potential program participants, and will serve 
                        a sufficient number of parents or guardians and 
                        their children, so as to allow for the 
                        formation of a control group, evaluation 
                        results to be adequately powered, and 
                        preliminary results of the evaluation to be 
                        available within 4 years of the program's 
                        implementation;
                            ``(iii) provide the entity or entities with 
                        technical assistance for the program design, 
                        including by working with 1 or more entities 
                        that are or have been involved in recovery 
                        coaching programs that have been rigorously 
                        evaluated and shown to increase family 
                        reunification and protect children so as to 
                        make sure the program conducted under the 
                        project adheres closely to the elements and 
                        protocol determined to be most effective in 
                        such other recovery coaching programs;
                            ``(iv) assist the entity or entities in 
                        securing adequate coaching, treatment, child 
                        welfare, court, and other resources needed to 
                        successfully conduct the family recovery and 
                        reunification program under the project; and
                            ``(v) ensure the entity or entities will be 
                        able to monitor the impacts of the program in 
                        the area or areas in which it is conducted for 
                        at least 5 years after parents or guardians and 
                        their children are randomly assigned to 
                        participate in the program or to be part of the 
                        program's control group.
            ``(4) Evaluation requirements.--
                    ``(A) In general.--The Secretary, in consultation 
                with the entity or entities conducting the family 
                recovery and reunification program under the project, 
                shall conduct an evaluation to determine whether the 
                program has been implemented effectively and resulted 
                in improvements for children and families. The 
                evaluation shall have 3 components: a pilot phase, an 
                impact study, and an implementation study.
                    ``(B) Pilot phase.--The pilot phase component of 
                the evaluation shall consist of the Secretary providing 
                technical assistance to the entity or entities 
                conducting the family recovery and reunification 
                program under the project to ensure--
                            ``(i) the program's implementation adheres 
                        closely to the elements and protocol determined 
                        to be most effective in other recovery coaching 
                        programs that have been rigorously evaluated 
                        and shown to increase family reunification and 
                        protect children; and
                            ``(ii) random assignment of parents or 
                        guardians and their children to be participants 
                        in the program or to be part of the program's 
                        control group is being carried out.
                    ``(C) Impact study.--The impact study component of 
                the evaluation shall determine the impacts of the 
                family recovery and reunification program conducted 
                under the project on the parents and guardians and 
                their children participating in the program. The impact 
                study component shall--
                            ``(i) be conducted using an experimental 
                        design that uses a random assignment research 
                        methodology;
                            ``(ii) consistent with previous studies of 
                        other recovery coaching programs that have been 
                        rigorously evaluated and shown to increase 
                        family reunification and protect children, 
                        measure outcomes for parents and guardians and 
                        their children over multiple time periods, 
                        including for a period of 5 years; and
                            ``(iii) include measurements of family 
                        stability and parent, guardian, and child 
                        safety for program participants and the program 
                        control group that are consistent with 
                        measurements of such factors for participants 
                        and control groups from previous studies of 
                        other recovery coaching programs so as to allow 
                        results of the impact study to be compared with 
                        the results of such prior studies, including 
                        with respect to comparisons between program 
                        participants and the program control group 
                        regarding--
                                    ``(I) safe family reunification;
                                    ``(II) time to reunification;
                                    ``(III) permanency (such as through 
                                measures of reunification, adoption, or 
                                placement with guardians);
                                    ``(IV) safety (such as through 
                                measures of subsequent maltreatment);
                                    ``(V) parental or guardian 
                                treatment persistence and engagement;
                                    ``(VI) parental or guardian 
                                substance use;
                                    ``(VII) juvenile delinquency;
                                    ``(VIII) cost; and
                                    ``(IX) other measurements agreed 
                                upon by the Secretary and the entity or 
                                entities operating the family recovery 
                                and reunification program under the 
                                project.
                    ``(D) Implementation study.--The implementation 
                study component of the evaluation shall be conducted 
                concurrently with the conduct of the impact study 
                component and shall include, in addition to such other 
                information as the Secretary may determine, 
                descriptions and analyses of--
                            ``(i) the adherence of the family recovery 
                        and reunification program conducted under the 
                        project to other recovery coaching programs 
                        that have been rigorously evaluated and shown 
                        to increase family reunification and protect 
                        children; and
                            ``(ii) the difference in services received 
                        or proposed to be received by the program 
                        participants and the program control group.
                    ``(E) Report.--The Secretary shall publish on an 
                internet website maintained by the Secretary the 
                following information:
                            ``(i) A report on the pilot phase component 
                        of the evaluation.
                            ``(ii) A report on the impact study 
                        component of the evaluation.
                            ``(iii) A report on the implementation 
                        study component of the evaluation.
                            ``(iv) A report that includes--
                                    ``(I) analyses of the extent to 
                                which the program has resulted in 
                                increased reunifications, increased 
                                permanency, case closures, net savings 
                                to the State or States involved (taking 
                                into account both costs borne by States 
                                and the Federal government), or other 
                                outcomes, or if the program did not 
                                produce such outcomes, an analysis of 
                                why the replication of the program did 
                                not yield such results;
                                    ``(II) if, based on such analyses, 
                                the Secretary determines the program 
                                should be replicated, a replication 
                                plan; and
                                    ``(III) such recommendations for 
                                legislation and administrative action 
                                as the Secretary determines 
                                appropriate.
            ``(5) Appropriation.--In addition to any amounts otherwise 
        made available to carry out this subpart, out of any money in 
        the Treasury of the United States not otherwise appropriated, 
        there are appropriated $15,000,000 for fiscal year 2019 to 
        carry out the project, which shall remain available through 
        fiscal year 2026.''.

SEC. 303. BUILDING CAPACITY FOR FAMILY-FOCUSED RESIDENTIAL TREATMENT.

    (a) Definitions.--In this section:
            (1) Eligible entity.--The term ``eligible entity'' means a 
        State, county, local, or tribal health or child welfare agency, 
        a private nonprofit organization, a research organization, a 
        treatment service provider, an institution of higher education 
        (as defined under section 101 of the Higher Education Act of 
        1965 (20 U.S.C. 1001)), or another entity specified by the 
        Secretary.
            (2) Family-focused residential treatment program.--The term 
        ``family-focused residential treatment program'' means a 
        trauma-informed residential program primarily for substance use 
        disorder treatment for pregnant and postpartum women and 
        parents and guardians that allows children to reside with such 
        women or their parents or guardians during treatment to the 
        extent appropriate and applicable.
            (3) Secretary.--The term ``Secretary'' means the Secretary 
        of Health and Human Services.
    (b) Support for the Development of Evidence-based Family-focused 
Residential Treatment Programs.--
            (1) Authority to award grants.--The Secretary shall award 
        grants to eligible entities for purposes of developing, 
        enhancing, or evaluating family-focused residential treatment 
        programs to increase the availability of such programs that 
        meet the requirements for promising, supported, or well-
        supported practices specified in section 471(e)(4)(C) of the 
        Social Security Act (42 U.S.C. 671(e)(4)(C))) (as added by the 
        Family First Prevention Services Act enacted under title VII of 
        division E of Public Law 115-123).
            (2) Evaluation requirement.--The Secretary shall require 
        any evaluation of a family-focused residential treatment 
        program by an eligible entity that uses funds awarded under 
        this section for all or part of the costs of the evaluation be 
        designed to assist in the determination of whether the program 
        may qualify as a promising, supported, or well-supported 
        practice in accordance with the requirements of such section 
        471(e)(4)(C).
    (c) Authorization of Appropriations.--There are authorized to be 
appropriated to the Secretary to carry out this section, $20,000,000 
for fiscal year 2019, which shall remain available through fiscal year 
2023.
                                                       Calendar No. 484

115th CONGRESS

  2d Session

                                S. 3120

                          [Report No. 115-284]

_______________________________________________________________________

                                 A BILL

 To amend titles XVIII and XIX of the Social Security Act to help end 
    addictions and lessen substance abuse disorders, and for other 
                               purposes.

_______________________________________________________________________

                             June 25, 2018

                 Read twice and placed on the calendar